Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Verrica Pharmaceuticals Inc (NQ: VRCA ) 7.050 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Verrica Pharmaceuticals Inc < Previous 1 2 3 4 5 6 7 Next > 12 Health Care Stocks Moving In Tuesday's Pre-Market Session September 21, 2021 Gainers Viridian Therapeutics (NASDAQ:VRDN) shares rose 18.05% to $12.62 during Tuesday's pre-market session. The company's market cap stands at $120.9 million.... Via Benzinga Verrica Pharma Shares Slide After Response Letter From FDA September 21, 2021 The FDA has issued a Complete Response Letter (CRL) regarding Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) marketing application seeking approval for VP-... Via Benzinga Exposures Product Safety 18 Stocks Moving in Tuesday's Pre-Market Session September 21, 2021 Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 37% to $1.78 in pre-market trading after declining around 4% on Monday. ReWalk Robotics, last month, reported Q2 sales of $1.44... Via Benzinga The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight September 19, 2021 Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical... Via Benzinga Exposures Product Safety 53 Biggest Movers From Friday September 07, 2021 Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform. Vera... Via Benzinga 35 Stocks Moving In Friday's Mid-Day Session September 03, 2021 Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 35% to $7.43. Cellect Biotechnology announced the first ApoGraft transplantation in a Leukemia patient in a... Via Benzinga Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates August 31, 2021 August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New... Via Benzinga 18 Key Biopharma Catalysts To Keep An Eye On In Q3 July 10, 2021 Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Here is a look at some catalysts for the biopharam sector in the... Via Talk Markets 18 Key Biopharma Catalysts To Keep An Eye On In Q3 July 10, 2021 Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Ne... Via Benzinga Verrica's VP-102 Application Review for Molluscum Contagiosum Delayed till September May 28, 2021 The FDA has extended the review period for the marketing application for Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) VP-102 to treat molluscum... Via Benzinga Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For May 14, 2021 May 14, 2021 Upgrades Canaccord Genuity upgraded the previous rating for Mogo Inc (NASDAQ:MOGO) from Hold to Speculative Buy. For the first quarter, Mogo had an EPS of $0.06, compared... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.